ArticleFrontiers in oncology2024

Efficacy of immune checkpoint inhibitors combined with bevacizumab in MSS/pMMR advanced colorectal cancer after first-line treatment failure.

Xiaoqian Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.